X0306 4 2021-01-20 0 0001773751 Hims & Hers Health, Inc. HIMS 0001837796 Dudum Andrew 2269 CHESTNUT STREET, #523 SAN FRANCISCO CA 94123 1 1 1 0 Chief Executive Officer Class A Common Stock 2021-01-20 4 A 0 8207151 A 8207151 I Held by Andrew Dudum 2015 Trust Dated July 2, 2015 Class A Common Stock 2021-01-20 4 A 0 2866230 A 2866230 I Held by AD GRAT dated 8/31/20 Class A Common Stock 2021-01-20 4 A 0 8268565 A 8268565 I Held by Atomic Labs II, L.P. Class V Common Stock 2021-01-20 4 A 0 8377623 0.00 A Class A Common Stock 8377623 8377623 I Held by Andrew Dudum 2015 Trust Dated July 2, 2015 Stock Option (right to buy) 2.43 2021-01-20 4 A 0 1623069 0.00 A 2030-06-16 Class A Common Stock 1623069 1623069 D Stock Option (right to buy) 2.43 2021-01-20 4 A 0 3246139 0.00 A 2030-06-16 Class A Common Stock 3246139 3246139 D Stock Option (right to buy) 2.43 2021-01-20 4 A 0 1623069 0.00 A 2030-06-16 Class A Common Stock 1623069 1623069 D Stock Option (right to buy) 9.41 2021-01-20 4 A 0 584797 0.00 A 2020-12-23 Class A Common Stock 584797 584797 D Restricted Stock Unit 2021-01-20 4 A 0 292625 0.00 A Class A Common Stock 292625 292625 D Restricted Stock Unit 2021-01-20 4 A 0 28624 0.00 A Class A Common Stock 28624 28624 D Warrant (right to buy) 11.50 2021-01-20 4 A 0 94582 0.00 A 2026-01-20 Class A Common Stock 94582 94582 I Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Warrant (right to buy) 11.50 2021-01-20 4 A 0 16028 0.00 A 2026-01-20 Class A Common Stock 16028 16028 I Held by Trustee of the AD GRAT dated 8/31/20 Warrant (right to buy) 11.50 2021-01-20 4 A 0 46238 0.00 A 2026-01-20 Class A Common Stock 46238 46238 I Held By Atomic Labs II, L.P. In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received (i) 6,700,108 shares of Class A Common Stock of New Hims and (ii) 1,507,043 shares of restricted New Hims Class A Common Stock (the "Earn Out Shares") in exchange for 15,516,292 shares of Class A Common Stock of Hims, Inc. The Earn Out Shares vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following closing (the "Earn Out Period"), then the unvested Earn Out Shares will be automatically forfeited. (Continued form footnote 1) On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share. In connection with the Merger, the Reporting Person received (i) 2,610,837 shares of Class A Common Stock of New Hims and (ii) 255,393 Earn Out Shares in exchange for 5,763,689 shares of Class A Common Stock of Hims, Inc. If the Earn Out Conditions are not met during the Earn Out Period, then the unvested Earn Out Shares will be automatically forfeited. In connection with the Merger, the Reporting Person received (i) 7,531,800 shares of Class A Common Stock of New Hims and (ii) 736,765 Earn Out Shares in exchange for 16,627,218 shares of Class A Common Stock of Hims, Inc. If the Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out Shares will be automatically forfeited. In connection with the Merger, the Reporting Person received shares of New Hims Class V Common Stock in exchange for shares of Class V Common Stock of Hims, Inc. As specified in that New Hims Certificate of Incorporation, dated as of January 20, 2021 (the "Charter"), New Hims Class V Common Stock is convertible into an equal number of fully paid and nonassessable shares of New Hims Class A Common Stock upon certain events. The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. The Stock Option was received in exchange for an option to purchase 7,166,182 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 100% of the shares subject to the Stock Option vest when (i) New Hims is acquired and the per share consideration is equal to at least $17.35 per share (subject to appropriate adjustment for the Merger, stock splits and otherwise, the "Threshold Amount") or (ii) the per share closing trading price of New Hims' Class A Common Stock on a public stock exchange is at least equal to the Threshold Amount (the date on which such closing trading price is achieved, the "Achievement Date"), provided that the Reporting Person remains in continuous service as CEO or a director through the acquisition or Achievement Date, as applicable. The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 100% of the shares subject to the option vest when (i) New Hims is acquired and the per share consideration is equal to at least the Threshold Amount or (ii) the per share closing trading price of New Hims' Class A Common Stock on a public stock exchange is at least equal to the Threshold Amount, provided that the Reporting Person remains in continuous service as CEO or a director of New Hims through the acquisition or Achievement Date, as applicable. The Stock Option was received in exchange for an option to purchase 1,291,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning with December 16, 2020. In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs"). The New Hims RSUs were received in exchange for 646,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service. The New Hims RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). The New Hims RSU expires in December 2027. In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out Shares (the "Earn Out RSUs"). The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 11 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out Conditions. If the RSU Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited. In connection with the Merger, the Reporting Person received additional New Hims warrants in exchange for Class A Common Stock of Hims, Inc. Mr. Dudum is a managing member of Atomic GP II, LLC, the general partner and manager of Atomic Labs II, L.P. Mr. Dudum may be deemed the beneficial owner of the shares held by Atomic Labs II, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. /s/ Soleil Boughton, Attorney-in-Fact 2021-01-22